Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

60 Degrees Pharmaceuticals Price to Free Cash Flow Ratio 2022-2024 | SXTP

Historical price to free cash flow ratio values for 60 Degrees Pharmaceuticals (SXTP) since 2022. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
60 Degrees Pharmaceuticals Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-09-20 1.37 0.00
2024-06-30 0.25 $-16.48 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.000B
60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $87.548B 34.88
Takeda Pharmaceutical (TAK) Japan $47.505B 9.51
Merck (MKGAF) Germany $24.427B 26.66
Astellas Pharma (ALPMY) Japan $21.987B 26.41
Sandoz Group AG (SDZNY) Switzerland $17.576B 0.00
Summit Therapeutics (SMMT) United States $16.780B 0.00
United Therapeutics (UTHR) United States $15.631B 16.15
Shionogi (SGIOY) Japan $13.344B 12.78
Neurocrine Biosciences (NBIX) United States $12.164B 36.39
Catalent (CTLT) United States $10.908B 0.00
Revolution Medicines (RVMD) United States $7.714B 0.00
Orion OYJ (ORINY) Finland $7.424B 30.23
Jazz Pharmaceuticals (JAZZ) Ireland $6.873B 7.29
Ionis Pharmaceuticals (IONS) United States $6.249B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.260B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.312B 0.00
Corcept Therapeutics (CORT) United States $4.276B 36.21
Dyne Therapeutics (DYN) United States $3.656B 0.00
PTC Therapeutics (PTCT) United States $2.782B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.727B 15.73
Arrowhead Pharmaceuticals (ARWR) United States $2.628B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.534B 20.14
Soleno Therapeutics (SLNO) United States $2.050B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.951B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.796B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.686B 0.00
Xencor (XNCR) United States $1.653B 0.00
Harrow (HROW) United States $1.649B 0.00
Cassava Sciences (SAVA) United States $1.457B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.446B 0.00
ARS Pharmaceuticals (SPRY) United States $1.441B 0.00
Ardelyx (ARDX) United States $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.410B 0.00
Indivior (INDV) United States $1.335B 6.13
Avadel Pharmaceuticals (AVDL) Ireland $1.309B 0.00
Evotec AG (EVO) Germany $1.290B 0.00
Collegium Pharmaceutical (COLL) United States $1.254B 7.20
Calliditas Therapeutics AB (CALT) Sweden $1.204B 0.00
Enliven Therapeutics (ELVN) United States $1.090B 0.00
Relay Therapeutics (RLAY) United States $1.052B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.030B 0.00
Bioventus (BVS) United States $0.938B 30.50
Cronos Group (CRON) Canada $0.852B 0.00
USANA Health Sciences (USNA) United States $0.766B 14.05
Savara (SVRA) United States $0.764B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.720B 45.10
4D Molecular Therapeutics (FDMT) United States $0.702B 0.00
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.678B 6.41
Exscientia (EXAI) United Kingdom $0.629B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.623B 0.00
Siga Technologies (SIGA) United States $0.609B 7.29
Tourmaline Bio (TRML) United States $0.579B 0.00
OmniAb (OABI) United States $0.559B 0.00
Eliem Therapeutics (ELYM) United States $0.555B 0.00
Silence Therapeutics (SLN) United Kingdom $0.548B 0.00
Altimmune (ALT) United States $0.538B 0.00
Foghorn Therapeutics (FHTX) United States $0.535B 0.00
Sage Therapeutics (SAGE) United States $0.482B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Aquestive Therapeutics (AQST) United States $0.474B 0.00
Larimar Therapeutics (LRMR) United States $0.456B 0.00
Verve Therapeutics (VERV) United States $0.455B 0.00
Xeris Biopharma Holdings (XERS) United States $0.441B 0.00
Zevra Therapeutics (ZVRA) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.415B 38.89
Theravance Biopharma (TBPH) Cayman Islands $0.402B 0.00
Lyell Immunopharma (LYEL) United States $0.399B 0.00
Organogenesis (ORGO) United States $0.388B 0.00
Aldeyra Therapeutics (ALDX) United States $0.359B 0.00
Korro Bio (KRRO) United States $0.358B 0.00
Lexeo Therapeutics (LXEO) United States $0.345B 0.00
Esperion Therapeutics (ESPR) United States $0.343B 0.00
Heron Therapeutics (HRTX) United States $0.306B 0.00
Akebia Therapeutics (AKBA) United States $0.288B 0.00
ESSA Pharma (EPIX) Canada $0.288B 0.00
Avita Medical (RCEL) United States $0.281B 0.00
Black Diamond Therapeutics (BDTX) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 17.59
Nanobiotix S.A (NBTX) France $0.251B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.241B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.235B 0.00
Nektar Therapeutics (NKTR) United States $0.234B 0.00
Pyxis Oncology (PYXS) United States $0.217B 0.00
CytoDyn (CYDY) United States $0.200B 0.00
Telomir Pharmaceuticals (TELO) United States $0.198B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Context Therapeutics (CNTX) United States $0.167B 0.00
VAXART, INC (VXRT) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.157B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Century Therapeutics (IPSC) United States $0.144B 0.00
Prelude Therapeutics (PRLD) United States $0.140B 0.00
Fractyl Health (GUTS) United States $0.130B 0.00
Assertio Holdings (ASRT) United States $0.129B 22.50
Incannex Healthcare (IXHL) Australia $0.121B 0.00
OptiNose (OPTN) United States $0.120B 0.00
Regulus Therapeutics (RGLS) United States $0.112B 0.00
Relmada Therapeutics (RLMD) United States $0.106B 0.00
Journey Medical (DERM) United States $0.105B 0.00
CASI Pharmaceuticals (CASI) China $0.101B 0.00
Citius Pharmaceuticals (CTXR) United States $0.099B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Vivani Medical (VANI) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Nutriband (NTRB) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
ProPhase Labs (PRPH) United States $0.048B 0.00
Inotiv (NOTV) United States $0.045B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
DURECT (DRRX) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
FibroGen (FGEN) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.041B 0.00
Protara Therapeutics (TARA) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.030B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MEI Pharma (MEIP) United States $0.021B 0.73
TherapeuticsMD (TXMD) United States $0.020B 0.00
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
Nuvilex (PMCB) United States $0.016B 0.00
Indaptus Therapeutics (INDP) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Vivos Therapeutics (VVOS) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.46
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.78